Skip to main content
Clinical Trials/NCT03461692
NCT03461692
Unknown
N/A

A Study of 100 Thousand Cases of Pediatric Patients of Clinical Safety Monitoring and Characteristic Observation and the Mechanism of Anaphylactic Reaction Used Reduning(a Chinese Medicine Injection)in Hospitals in China

China Academy of Chinese Medical Sciences0 sites100,000 target enrollmentMarch 10, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Upper Respiratory Tract Infection
Sponsor
China Academy of Chinese Medical Sciences
Enrollment
100000
Primary Endpoint
Incidence of Adverse Drug Reaction
Last Updated
8 years ago

Overview

Brief Summary

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in February 2018.

The purpose of this study is to make a monitoring of adverse reactions in 100 thousand children aged 14 years and below to see whether Reduning injection is safe and the characteristic and mechanism of anaphylactic reaction used Reduning injection in hospitals in China.

Detailed Description

In order to observe the clinical characteristics and adverse reactions of patients aged 14 and below using Reduning injection in hospital,registry study is suitable method in this area. Otherwise, nested case control study is used to find out the mechanism of anaphylaxis. Calculating the incidence of adverse drug reactions is one of the main aims for this study. 100000 cases need to be registered at least. The aim population is who using Reduning injection from February 2018 to December 2018.

Registry
clinicaltrials.gov
Start Date
March 10, 2018
End Date
December 31, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yanming Xie

Deputy Director

China Academy of Chinese Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients aged 14 and below using Reduning injection from February 2018 to December 2018.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of Adverse Drug Reaction

Time Frame: 3 days

Incidence of Reduning Injection'Adverse Drug Reaction(ADRs)and Identify Factors That Contributed to the Occurrence of the Adverse Drug Reaction

Secondary Outcomes

  • The Ratio of Body Temperature to Normal(3 days)
  • The Ratio of WBC to Normal(3 days)
  • The Ratio of The Antibiotic Used(3 days)

Similar Trials